Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

INVO Fertility (IVF) EBIAT (2016 - 2025)

INVO Fertility has reported EBIAT over the past 15 years, most recently at -$2.6 million for Q3 2025.

  • Quarterly EBIAT fell 62.18% to -$2.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$29.0 million through Sep 2025, down 289.59% year-over-year, with the annual reading at -$9.1 million for FY2024, 13.7% down from the prior year.
  • EBIAT was -$2.6 million for Q3 2025 at INVO Fertility, up from -$5.3 million in the prior quarter.
  • Over five years, EBIAT peaked at $97018.0 in Q4 2021 and troughed at -$17.4 million in Q1 2025.
  • The 5-year median for EBIAT is -$2.5 million (2021), against an average of -$3.2 million.
  • Year-over-year, EBIAT soared 102.58% in 2021 and then crashed 2952.08% in 2022.
  • A 5-year view of EBIAT shows it stood at $97018.0 in 2021, then crashed by 2952.08% to -$2.8 million in 2022, then increased by 29.16% to -$2.0 million in 2023, then tumbled by 84.86% to -$3.6 million in 2024, then rose by 27.01% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's EBIAT are -$2.6 million (Q3 2025), -$5.3 million (Q2 2025), and -$17.4 million (Q1 2025).